Sio-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
54
Total Value
335797884
Accession Number
0001214659-25-007756
Form Type
13F-HR
Manager Name
Sio-Capital-Management
Data Enrichment
94% identified
51 identified3 unidentified

Holdings

54 positions
Manager:
Search and click to pin securities to the top
Page 3 of 3
ENANTA PHARMACEUTICALS INC
Shares:177.0K
Value:$977.1K
Context Therapeutics Inc.
Shares:1.3M
Value:$813.0K
TELA Bio, Inc.
Shares:630.0K
Value:$768.6K
Ovid Therapeutics Inc.
Shares:2.2M
Value:$696.2K
Avalo Therapeutics, Inc.
Shares:71.5K
Value:$572.4K
Aprea Therapeutics, Inc.
Shares:276.6K
Value:$564.3K
Foghorn Therapeutics Inc.
Shares:121.7K
Value:$444.1K
B6S7WD106
Shares:50.8K
Value:$354.9K
Modular Medical, Inc.
Shares:252.0K
Value:$274.7K
Boundless Bio, Inc.
Shares:162.1K
Value:$244.7K
NextCure, Inc.
Shares:130.0K
Value:$62.4K
Terns Pharmaceuticals, Inc.
Shares:10.0K
Value:$27.6K
Humacyte, Inc.
Shares:50.0K
Value:$18.1K
77313F114
Shares:400.0K
Value:$17.1K